Ras family genes: An interesting link between cell cycle and cancer

被引:118
作者
Macaluso, M
Russo, G
Cinti, C
Bazan, V
Gebbia, N
Russo, A
机构
[1] Univ Palermo, Reg Reference Ctr Biomol Characterizat Neoplasms, Sect Oncobiol, Dept Clin Oncol, I-90133 Palermo, Italy
[2] Inst Normal & Pathol Cytomorphol, CNR, Bologna, Italy
[3] Univ Palermo, Reg Reference Ctr Biomol Characterizat Neoplasm &, Sect Chemotherapy, Dept Clin Oncol, I-90133 Palermo, Italy
[4] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
关键词
D O I
10.1002/jcp.10109
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ras genes are evolutionary conserved and codify for a monomeric G protein binding GTP (active form) or GDP (inactive form). The ras genes are ubiquitously expressed although mRNA analysis suggests different level expression in tissue. Mutations in each ras gene frequently were found in different tumors, suggesting their involvement in the development of specific neoplasia. These mutations lead to a constitutive active and potentially oncogenic protein that could cause a deregulation of cell cycle. Ras protein moderates cellular responses at several mitogens and/or differentiation factors and at external stimuli. These stimuli activate a series of signal transduction pathways that either can be independent or interconnected at different points. Recent observations begin to clarify the complex relationship between Ras activation, apoptosis, and cellular proliferation. A greater understanding of these processes would help to identify the factors directly responsible for cell cycle deregulation in several tumors, moreover it would help the design of specific therapeutic strategies, for the control oil the proliferation of neoplastic cells. We summarize here current knowledge of ras genes family: structural and functional characteristics of Ras proteins and their inks with cell cycle and cancer. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 60 条
[1]  
Adjei A. A., 2000, P ASCO, V19, P722
[2]   Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1) [J].
Aktas, H ;
Cai, H ;
Cooper, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) :3850-3857
[3]   Regulation of NF-κB RelA phosphorylation and transcriptional activity by p21ras and protein kinase Cζ in primary endothelial cells [J].
Anrather, J ;
Csizmadia, V ;
Soares, MP ;
Winkler, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13594-13603
[4]   RAS and leukemia:: From basic mechanisms to gene-directed therapy [J].
Beaupre, DM ;
Kurzrock, R .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :1071-1079
[5]   The structural basis of the activation of Ras by Sos [J].
Boriack-Sjodin, PA ;
Margarit, SM ;
Bar-Sagi, D ;
Kuriyan, J .
NATURE, 1998, 394 (6691) :337-343
[6]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[7]  
BOS JL, 1989, CANCER RES, V49, P4682
[9]   Fibronectin, integrins, and growth control [J].
Danen, EHJ ;
Yamada, KM .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 189 (01) :1-13
[10]   Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice [J].
DeLong, RK ;
Nolting, A ;
Fisher, M ;
Chen, Q ;
Wickstrom, E ;
Kligshteyn, M ;
Demirdji, S ;
Caruthers, M ;
Juliano, RL .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (02) :71-77